Navigation Links
NYU Langone Medical Center Study Shows VNS Therapy is a Safe and Effective Treatment for Refractory Epilepsy
Date:12/4/2009

BOSTON and HOUSTON, Dec. 4 /PRNewswire-FirstCall/ -- AES Annual Meeting, Booth #901-- Cyberonics, Inc. (Nasdaq: CYBX) announced today that Vagus Nerve Stimulation (VNS) Therapy, the only FDA-approved implantable medical device for the treatment of refractory epilepsy, will be featured in 14 presentations at the American Epilepsy Society's (AES) Annual Meeting, taking place December 4-8 at the Hynes Convention Center in Boston, Massachusetts.

Robert Elliott, M.D., chief resident of Neurosurgery at NYU Langone Medical Center, will present results of the study entitled, "Vagus Nerve Stimulation for Refractory Epilepsy: Single Surgeon Experience of over 700 Consecutive Operations," on Monday, December 7 at 4:00 p.m. The study was designed to analyze the efficacy and safety of VNS Therapy in a large series of consecutive adults and children with medically refractory epilepsy.

Dr. Elliott and his colleagues at NYU Langone Medical Center conducted a retrospective review of 507 consecutive patients with refractory epilepsy who underwent a total of 720 VNS-related procedures between November 1997 and April 2008. Outcome analysis was performed on 436 patients who underwent primary implantation at the center and had at least one year of follow-up since implantation. Duration of VNS Therapy ranged from one week to 11.35 years.

The results showed a more than 50 percent reduction in seizure frequency occurred in 64.6 percent of patients and 42.1 percent of patients experienced more than a 70 percent reduction in seizure frequency. Patients who had failed i
'/>"/>

SOURCE Cyberonics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Kenneth G. Langone, Home Depot Co-Founder, Chairman of the NYU Langone Medical Center, to Lead 65th Annual Columbus Day Parade as Grand Marshal
2. NYU Langone Medical Centers tip sheet to the 45th Annual Meeting of ASCO
3. NYU Langone Medical Center study shows that cochlear implant surgery is safe for the elderly
4. SIRIUS Satellite Radio & NYU Langone Medical Center Launch Doctor Radio Channel
5. NYU Langone Medical Centers tip sheet to the 44th annual meeting of ASCO
6. North American Seminars Inc. Opens Its 2010 Physical Therapy Continuing Medical Education Course Sponsorship Program
7. IntelliSoft Group Focuses on Protecting Customer Investment in Medical Credentialing Systems -- Budget Constraints and Forced Upgrades in Medical Credentialing Automation
8. Florida Medical Association Marks Record Membership Growth
9. Topping Out Ceremony Marks Milestone in Construction of University Medical Center of Princeton at Plainsboro
10. Chiltern Names Dr. Sharon Moore as Executive VP, Global Quality & Medical Affairs
11. Personality predicts success in medical school, says new study by U of Minnesota professor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/23/2014)... scientists report that rats exposed to high-energy particles, simulating ... mission, show lapses in attention and slower reaction times, ... dose ranges. , The cognitive impairments which affected ... animals appear to be linked to protein changes ... found to hold true in humans, suggest it may ...
(Date:4/23/2014)... of the gastro-intestinal tract has long been considered to ... the Sahlgrenska Academy have used refined microscopic techniques that ... surface of the gastro-intestinal tract is only as large ... , The digestive tract, which passes from the mouth ... a length of about 5 meters in a normal ...
(Date:4/23/2014)... 2014) The American Gastroenterological Association (AGA) Research ... Research Scholars. The AGA Research Scholar Awards program, ... independent and productive research careers in digestive diseases. ... an additional year allowing for three consecutive years ... junior faculty who are paving the way for ...
(Date:4/23/2014)... 21, 2014 Five for-profit and non-profit organizations ... million in Proof of Concept grants to accelerate ... commercial products, the Life Sciences Discovery Fund (LSDF) ... Mentoring Program grant to the Washington Biotechnology & ... network to train the next generation of entrepreneurs ...
(Date:4/23/2014)... published in the journal Oncotarget , explored ... appearances or their own DNA signatures within the ... to design effective, targeted treatment strategies. , Firstly ... mutation and either the KRAS or BRAF mutation. ... the EGFR gene mutation have that specific mutation ...
Breaking Medicine News(10 mins):Health News:Some astronauts at risk for cognitive impairment, animal studies suggest 2Health News:Some astronauts at risk for cognitive impairment, animal studies suggest 3Health News:The surface area of the digestive tract 'only' as large as a studio apartment 2Health News:AGA announces 2014 Class of AGA Research Scholars 2Health News:LSDF announces commercialization grants and Entrepreneur Mentoring Program 2Health News:Non-uniform genetic mutations identified in lung cancers could lead to targeted treatment 2
... toward oral chemotherapy agents offers cancer patients greater freedom and ... medications also poses more chances for patients to skip doses, ... way. An increasing number of cancer patients who receive chemotherapy ... pill bottle each day rather than the drip of an ...
... 28 APS Healthcare, a leading provider of ... Oregon Department of Human Services (DHS), Division of ... disease and medical care management programs. The integrated ... clients to access healthcare, minimize catastrophic health events ...
... FRANCISCO, May 28 Funding for poison control services ... Poison control services cost California $5.9 million but save ... emergency room visits each year. Not only do ... the toll-free number, but emergency room doctors and nurses ...
... A new statewide poll of registered voters ... bill to give the U.S. Food and Drug Administration (FDA) ... is expected to debate this issue next week, and Senators ... whether Congress will finally pass this life-saving legislation.(Logo: ...
... The Centre for Epidemiological Studies into Sexually-Transmitted Diseases and ... Spain in 2005 to look into the prevalence of ... objective was to monitor the rates of infection with ... as the prevalence of risky behaviour. , "The ...
... A new statewide poll of registered voters finds that ... give the U.S. Food and Drug Administration (FDA) the authority ... to debate this issue next week, and Senators Cochran and ... will finally pass this life-saving legislation.(Logo: http://www.newscom.com/cgi-bin/prnh/20080918/CFTFKLOGO ...
Cached Medicine News:Health News:Compliance and cost: Bitter pills to swallow in the age of oral chemotherapy 2Health News:Compliance and cost: Bitter pills to swallow in the age of oral chemotherapy 3Health News:Oregon Department of Human Services Selects APS Healthcare to Manage Expanded Statewide Medicaid Program 2Health News:Oregon Department of Human Services Selects APS Healthcare to Manage Expanded Statewide Medicaid Program 3Health News:California to Become Only State Without Poison Control Services 2Health News:New Virginia Poll: 71 Percent of Voters Strongly Support FDA Regulation of Tobacco Products 2Health News:New Virginia Poll: 71 Percent of Voters Strongly Support FDA Regulation of Tobacco Products 3Health News:Spanish prostitutes least likely to use condoms 2Health News:New Mississippi Poll: Voters Strongly Support FDA Regulation of Tobacco Products 2Health News:New Mississippi Poll: Voters Strongly Support FDA Regulation of Tobacco Products 3
(Date:1/15/2014)... Jan. 15, 2014  According to Millennium Research Group ... intelligence, the United States ... markets will expand moderately through 2022, with embolization ... particular, increasing interest in drug-eluting beads (DEBs) and ...
(Date:1/15/2014)... , Jan. 15, 2014 Reportlinker.com ... is available in its catalogue: ... Drug Forecast and Market Analysis to 2022 ... PharmaPoint: Atopic Dermatitis - India Drug Forecast ...
(Date:1/15/2014)... NEW YORK , Jan. 15, 2014 ... research report is available in its catalogue: ... Technologies for Advanced Drug Delivery Systems -- ... http://www.reportlinker.com/p01940411/Global-Markets-and-Technologies-for-Advanced-Drug-Delivery-Systems----Focus-on-End-Users.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology STUDY OBJECTIVES ...
Breaking Medicine Technology:US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 16Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 17Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 18
... has,received a Complete Response Letter from the U.S. ... Application (NDA) for a,controlled-release form of hydrocodone with ... will discuss the letter with,the FDA, and will ... seeking the approval of controlled-release hydrocodone with,acetaminophen as ...
... 20 Alsius Corporation,(Nasdaq: ALUS ), the ... announced that four scientific,posters featuring both patient cases ... utilized will be presented this week at the ... in Orlando., Dr. Arie Blitz, Director of ...
Cached Medicine Technology:Thermogard XP(TM) Studies to Be Presented at American Society of Anesthesiologists Annual Meeting 2Thermogard XP(TM) Studies to Be Presented at American Society of Anesthesiologists Annual Meeting 3
70 discs to investigate acquired color deficiency. Quantifies neutral zone characteristics of dyschromatopsia and evaluates the relative luminance....
... 15 disc test (P/N LD15C) include a ... comprehensive instructions. P/N LD15C also includes a ... tip covers for the test subjects fingers ... the color discs). Beware that these finger ...
Solo-care is a multi-purpose solution for cleaning, rinsing, disinfection and storing soft contact lenses....
Opti-Free Express multi-purpose disinfecting solution lasting comfort No Rub formula provides triple action protection for your contact lenses....
Medicine Products: